Charles Rowland, Jr.

Former Chief Financial Officer & Vice President at Shire ViroPharma, Inc.

Charles Rowland, Jr.

Charles Rowland, Jr.

Former Chief Financial Officer & Vice President at Shire ViroPharma, Inc.

Career Highlights

Shire ViroPharma, Inc.
Endo International Plc
ViroPharma, Inc.

RelSci Relationships


Number of Boards






Number of Awards


RelSci Relationships are individuals Charles Rowland, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Nabriva Therapeutics GmbH

Relationship likelihood: Strong

Chairman at Surface Oncology, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Correvio Pharma Corp.

Relationship likelihood: Strong

Co-Founder at Mereo BioPharma Group Plc

Relationship likelihood: Strong

Venture Partner at Kearny Venture Partners

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Spark Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Viking Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer, President & Member of the Board of Directors at Blueprint Medicines Corp.

Relationship likelihood: Strong

Professional at Talbot Advisors LLC

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at Inozyme Pharma, Inc.

Relationship likelihood: Strong

Paths to Charles Rowland, Jr.
Potential Connections via
Relationship Science
Charles Rowland, Jr.
Former Chief Financial Officer & Vice President at Shire ViroPharma, Inc.
Bachelor's of Science in Accounting

Saint Joseph's University is a private, coeducational Roman Catholic Jesuit university located in the Philadelphia suburb of Merion Station

Master of Business Administration

Rutgers Business School – Newark and New Brunswick (Rutgers Business School, RBS) is the graduate and undergraduate business school located on the Newark and New Brunswick campuses of Rutgers University. It was founded in 1929. Rutgers Business School offers bachelor's, master's, and Ph.D. degrees. It offers Master of Business Administration (MBA) degrees with concentrations in Accounting, Finance, Supply Chain Management, Pharmaceutical Management, Marketing, Market Research, Insights, & Analytics, Entrepreneurship, Management & Business Strategy, Global Business, and Information Management & Analytics. A concentration in Real Estate was added to the curriculum in 2013. The Rutgers Business School also offers a 14-month MBA in Public Accounting and masters degrees in Accounting (MACCY), Quantitative Finance (MQF), and Information Technology (MIT).

Career History
Chief Financial Officer & Vice President
2008 - 2014

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs. We focus on providing products to physician specialists that support patients with serious diseases for which there is an unmet medical need, including disease caused by C1 esterase inhibitor deficiency and C. difficile. In everything we do, throughout our organization, we are committed to patient and physician needs, as we work to bring new products to markets with few, if any, therapeutic options. We are dedicated to transforming the promise of biotechnology into therapies that have the power to restore health and save lives.

President & Chief Executive Officer
2016 - 2017

Aurinia Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Executive Vice President, Chief Financial Officer & Treasurer
Prior - 2008

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.S. Branded Pharmaceuticals, U.S. Generic pharmaceuticals and International Pharmaceuticals. The U.S. Branded Pharmaceuticals offers products that focus on the treatment and management of conditions in urology, urologic oncology, endocrinology, and orthopedics. The U.S. Generic pharmaceuticals segment consist of a differentiated product portfolio including high-barrier-to-entry products, first-to-file or first-to-market opportunities that are difficult to formulate, difficult to manufacture or face complex legal and regulatory challenges. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. Endo International was founded in 1997 and is headquartered Dublin, Ireland.

Boards & Committees
Independent Non-Executive Director
2018 - Current

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of gene therapies. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). It operates through the following geographical segments: United Kingdom, European Union, and United States. The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.

Member, Board of Directors
2018 - Current

Generation Bio Co. develops and provides genetic medicines. It offers GeneWave, a therapeutic application for ceDNA. GeneWave technology delivers ceDNA with Lipid Nanoparticles to the liver, creating a capsid-free gene therapy that provides durable gene expression, which can be titrated to effect, and re-dosed to create a sustainable lifetime benefit for patients. The company was founded by Mark D. Angelino and Robert M. Kotin in 2016 and is headquartered in

Non-Executive Director
2017 - Current

PsiOxus Therapeutics Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Political Donations

The National Republican Congressional Committee (NRCC) is the Republican Hill committee which works to elect Republicans to the United States House of Representatives. The NRCC was formed in 1866, when the Republican caucuses of the House and Senate formed a "Congressional Committee". It supports the election of Republicans to the House through direct financial contributions to candidates and Republican Party organizations; technical and research assistance to Republican candidates and Party organizations; voter registration, education and turnout programs; and other Party-building activities.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Charles Rowland, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Charles Rowland, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Charles Rowland, Jr..
  • be_ixf; php_sdk; php_sdk_1.4.15